Pharma Mar, S.A. (BME:PHM)
81.10
-2.10 (-2.52%)
Mar 31, 2025, 2:37 PM CET
Pharma Mar Revenue
In the year 2024, Pharma Mar had annual revenue of 174.86M EUR with 10.56% growth. Pharma Mar had revenue of 48.36M in the quarter ending December 31, 2024, with 19.38% growth.
Revenue
174.86M
Revenue Growth
+10.56%
P/S Ratio
8.35
Revenue / Employee
349.71K
Employees
500
Market Cap
1.46B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 174.86M | 16.70M | 10.56% |
Dec 31, 2023 | 158.15M | -38.19M | -19.45% |
Dec 31, 2022 | 196.34M | -33.49M | -14.57% |
Dec 31, 2021 | 229.83M | -40.13M | -14.87% |
Dec 31, 2020 | 269.96M | 184.14M | 214.57% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Grifols | 7.21B |
Laboratorios Farmaceuticos Rovi | 763.75M |
Almirall | 990.63M |
Faes Farma | 510.04M |
Clínica Baviera | 265.72M |
Atrys Health | 211.11M |
Laboratorio Reig Jofre | 338.90M |
Oryzon Genomics | 7.36M |
Pharma Mar News
- 26 days ago - Pharma Mar SA (PHMMF) Q4 2024 Earnings Call Highlights: Record Profits and Strategic Advances - GuruFocus
- 2 years ago - Pharma Mar, S.A. (PHMMF) Q4 2022 Earnings Call Transcript - Seeking Alpha
- 3 years ago - Pharma Mar, S.A. (PHMMF) Management on Q4 2021 Results - Earnings Call Transcript - Seeking Alpha